Patient-centered drug development and the Learning Health System
Erin Moore | e.keeleymoore@gmail.com |
Leigh Anne Naas | naasla@lilly.com |
Laura Crawford | crawford_laura@lilly.com |
Abstract
Patient-centered drug development (PCDD) is a shift in the way drugs are developed, systematically incorporating patient participation in all stages of medicine development. We will discuss how the Learning Health System can facilitate PCDD by connecting stakeholders and enabling efficient flow of data, information, and evidence in the health ecosystem.